The analysis of clonal diversity and therapy responses using STAT3 mutations as a molecular marker in large granular lymphocytic leukemia.

Rajala, Hanna L M

The analysis of clonal diversity and therapy responses using STAT3 mutations as a molecular marker in large granular lymphocytic leukemia. [electronic resource] - Haematologica Jan 2015 - 91-9 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

1592-8721

10.3324/haematol.2014.113142 doi


Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Arthritis, Rheumatoid--genetics
Biomarkers--analysis
Clonal Evolution--genetics
Female
Follow-Up Studies
High-Throughput Nucleotide Sequencing--methods
Humans
Killer Cells, Natural--drug effects
Leukemia, Large Granular Lymphocytic--drug therapy
Male
Middle Aged
Mutation--genetics
Neoplasm Staging
Prognosis
Receptors, Antigen, T-Cell, alpha-beta--genetics
STAT3 Transcription Factor--genetics
T-Lymphocytes--drug effects
Young Adult